Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective.

Target Oncol · 2023 · PMC9928940 · PMID 36745342

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

36.1 months), the difference between active treatment and the observation group did not reach statistical significance (HR: 0.84; 95% CI: 0.67–1.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.